NCT00380471

UnknownPhase 2

Treatment and Complication of Bath PUVA in Vitiligo

Shahid Beheshti University of Medical Sciences Source

Compare

Other study identifiers

Sponsor study identifier

src-pts-968

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

January 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

August 2006

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

The purpose of this study is to determine whether bath PUVA are effective in treatment of vitiligo and what is the complication of bath PUVA in vitiligo.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Reported enrollment (type unavailable): Not reported
Study completion date: August 2006
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2006
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
August 2006
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
First Submitted
September 25, 2006
Actual (reported)
First Posted
September 26, 2006
Actual (reported)

Last Updated: January 23, 2008
Status Verified: January 2008
Last Update Submitted: January 22, 2008

Conditions

Vitiligo

Keywords

bath PUVA

Interventions

Bath PUVADevice

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 70 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Vitiligo

You may not qualify if:

Sponsors & Collaborators

Shahid Beheshti University of Medical Sciences
Otherlead

Study Sites (1)

Skin Research Center, Shaheed Beheshti Medical University

Tehran, 19899, Iran

RECRUITING

Parviz Toossi, M.D.CONTACT98-21-22744392 src@sbmu.ac.ir

Parviz Toossi, M.D.PRINCIPAL INVESTIGATOR

Fatemeh Aryanejad, MDSUB INVESTIGATOR

Gita Meshkat Razavi, MDSUB INVESTIGATOR

MeSH Terms

Conditions

Vitiligo

Condition Hierarchy (Ancestors)

HypopigmentationPigmentation DisordersSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

Parviz Toossi, M.D.
Shahid Beheshti University of Medical Sciences
STUDY CHAIR

Central Study Contacts

Parviz Toossi, M.D.

CONTACT

98-21-22744392 src@sbmu.ac.ir

Study Design

Study Type: interventional
Phase: phase 2
Allocation: NON RANDOMIZED
Masking: SINGLE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER

Study Record Dates

First Submitted

September 25, 2006

First Posted

September 26, 2006

Study Start

January 2006

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

August 2006

Estimated (date passed)

NCT07820098

Topical Delgocitinib for Facial Vitiligo

Phase 2Active Not Recruiting

NCT01766609

Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo

Phase 2Unknown

NCT01787695

UVA 1 Phototherapy for Vitiligo

Phase 2Unknown

NCT03099304

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Phase 2Completed

NCT01517893

Clinical Trial of Simvastatin to Treat Generalized Vitiligo

Phase 2Completed

NCT02809976

Topical Ruxolitinib for the Treatment of Vitiligo

Phase 2Completed

Pregnancy

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

January 23, 2008

Record last verified: 2008-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00380471
Data provider: ClinicalTrials.gov
Source updated: 2008-01-23
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:35:59 UTC

Locations

IR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations